Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 6, Number 4—August 2000

Neisseria meningitidis Serogroup W135 Isolates Associated with the ET-37 Complex

On This Page
Article Metrics
citations of this article
EID Journal Metrics on Scopus

Cite This Article

To the Editor: As of April 20, 2000, >300 laboratory-confirmed cases of meningococcal disease caused by N. meningitidis serogroup W135 (NMW135) have been reported in Saudi Arabia and nine other countries among Hajj pilgrims or their close contacts (1). This is the first multinational outbreak of W135 meningococcal disease. NMW135 accounts for <5% of meningococcal disease in the United States and worldwide. The main cause of meningococcal disease outbreaks, especially in the African "meningitis belt," which extends from Ethiopia in the east to Senegal in the west, has long been N. meningitidis serogroup A. An epidemic, caused by a particular clonal group of serogroup A, identified by multilocus enzyme electrophoresis (MEE) as subgroup III-1, occurred in Nepal (1983 and 1984), Pakistan and India (1985) (2) and may have caused earlier epidemics in China. In 1987, an outbreak of group A meningococcal disease caused by the same clonal group occurred in association with the annual Moslem pilgrimage to Mecca (Hajj) (3). At that time, Saudi Arabia implemented vaccination requirements for all entering pilgrims. The vaccine formulations vary; bivalent A/C vaccine or quadrivalent A/C/Y/W135 vaccine (as licensed in the United States) is used.

We present molecular characterization results of NMW135 isolates from four U.S. patients with meningococcal disease. These cases were epidemiologically linked to this year's Hajj in Saudi Arabia that concluded on March 17, 2000 (4). We examine the origin and potential relatedness of the NMW135 isolates to some of the major N. meningitidis virulent clones. Two patients (both vaccinated with quadrivalent A/C/Y/W135 vaccine) were returning pilgrims; one was a close household contact of another pilgrim, the other had other possible contacts with the U.S. pilgrims. Three isolates were identified as NMW135 at the New York City Health Department and the fourth at the California Department of Health. Serogroup identification was confirmed at the Centers for Disease Control and Prevention by standard microbiologic methods (CDC) (5).

MEE has long been the standard method for molecular subtyping of N. meningitidis and has allowed identification of several major epidemic-prone clones. When the MEE system established by Caugant et al. (6) and that used at CDC were recently compared, they demonstrated excellent correlation segregating individual electrophoretic types (ETs) into similar clusters. A virulent clone, designated ET-37 complex, which contains >50 different ETs, is mainly composed of N. meningitidis serogroup C. In the United States, strains of ET-24 (within the ET-37 complex) are the main cause of meningococcal disease outbreaks and among the most frequent causes of sporadic meningococcal disease (7). The four Hajj-associated NMW135 isolates were of ET-927, which is located in a small cluster more closely related to the ET-37 complex (at a genetic distance <0.20) than to any other NMW135 isolate or any other major virulent clonal group among >2,000 N. meningitidis isolates in our collection (8). This cluster contains two other NMW135 isolates: one from Indonesia from a pilgrim returning from the 1996 Hajj and another from Canada (1997) for which additional epidemiologic information is not available.

Serotyping and serosubtyping showed that all four W135 isolates were 2a:P1.5,2, most frequently seen in N. meningitidis serogroup B and C isolates (9). Sequencing of the variable regions (VR) of the porA gene showed that these four isolates had VR1 and VR2 sequences identical to those of the prototype P1.5,2 strain. Strains of the same serogroup/serosubtype have been already identified in France and the Netherlands isolated from four patients with Hajj 2000 association (1), and earlier in Gambia (1990-1995) and Mali (1995) (10). A single NMW135 isolate from Gambia and one from Mali are listed in the multilocus sequence typing (MLST) database (Oxford database) as being of sequence type 11, typically seen in isolates of the ET-37 complex (11). MLST provides results comparable to those of MEE for classification and taxonomic purposes. We are evaluating the usefulness of MLST for outbreak studies. The DNA sequences of the 16S rRNA gene of the four Hajj-associated NMW135 isolates were identical to each other and to those of the California (1995) outbreak-related serogroup C ET-24 strains and an Ohio (1997) sporadic serogroup C ET-24 strain. The 16S rRNA gene sequences of 66 N. meningitidis isolates representing serogroups A, B, C, W135, Z, and Y were diverse, with nine different sequences among the NMW135 isolates. Finally, all four recent NMW135 isolates had identical NheI pulsed-field gel electrophoresis (PFGE) patterns distinct from patterns seen in other NMW135 isolates. All these molecular markers were clearly unique in NMW135 isolates previously identified in the United States or isolated at the same time as the Hajj-associated isolates but with no epidemiologic link to the current outbreak. These unique markers allowed easy differentiation of the imported, Hajj-associated isolates from other sporadic NMW135 isolates circulating in the United States.

It has been shown previously that NMW135 strains can exist in widely divergent clonal groups. Our data suggest that strains like those associated with this year's Hajj have been in circulation in human populations for at least several years in different parts of the world. Given that the Hajj is a large, yearly event, high-level exposure of pilgrims to respiratory secretions and subsequent spread of infection to many countries by returning pilgrims may turn W135 meningococcal disease into a global health threat. Continued surveillance, as well as increased awareness of meningococcal disease caused by N. meningitidis of this serogroup by physicians and the public, is needed. Efforts to measure the efficacy of the quadrivalent meningococcal vaccine for prevention of W135 meningococcal disease should be considered. To get a better global understanding of W135 meningococcal disease, we are conducting a large multicenter study on molecular characterization of >50 Hajj-associated NMW135 isolates from Saudi Arabia, France, Singapore, and Finland, and 50 other W135 isolates from throughout the world.


Tanja Popovic*, C.T. Sacchi*, M.W. Reeves*, A.M. Whitney*, L.W. Mayer*, C.A. Noble*, G.W. Ajello*, F. Mostashari*†, N. Bendana‡, J. Lingappa*, Rana Hajjeh*, and N.E. Rosenstein*
Author affiliations: Centers for Disease Control and Prevention, Atlanta, Georgia, USA; †New York City Department of Health, New York, New York, USA; ‡California Department of Health, Los Angeles, California, USA



  1. Samuelsson  S, Handysides  S, Ramsay  M, Lyytikainen  O, Nygard  K, Perrocheau  A, Meningococcal infection in pilgrims returning from the haj: update from Europe and beyond. Eurosurveillance Weekly. 2000;17:15.
  2. Achtman  M. Molecular epidemiology of epidemic bacterial meningitis. Rev Med Microbiol. 1990;1:2938.
  3. Novelli  VM, Lewis  RG, Dawood  ST. Epidemic group A meningococcal disease in Haj pilgrims. Lancet. 1987;2:863. DOIPubMedGoogle Scholar
  4. Centers for Disease Control and Prevention. Serogroup W135 meningococcal disease among travelers returning from Saudi Arabia--United States, 2000. MMWR Morb Mortal Wkly Rep. 2000;49:3456.PubMedGoogle Scholar
  5. Popovic  T, Ajello  G, Facklam  R. Laboratory manual for the diagnosis of meningitis caused by Neisseria meningitidis, Streptococcus pneumoniae, and Haemophilus influenzae. Geneva: World Health Organization; 1999.
  6. Caugant  D. Population genetics and molecular epidemiology of Neisseria meningitidis. APMIS. 1998;106:50525. DOIPubMedGoogle Scholar
  7. Rosenstein  NE, Perkins  BA, Stephens  D, Lefkowitz  L, Cartter  ML, Danila  R, The changing epidemiology of meningococcal disease in the United States, 1992-1996. J Infect Dis. 1999;180:1894901. DOIPubMedGoogle Scholar
  8. Reeves  MW, Perkins  BA, Diermayer  M, Wenger  JD. Epidemic-associated Neisseria meningitidis detected by multilocus enzyme electrophoresis. Emerg Infect Dis. 1995;1:534. DOIPubMedGoogle Scholar
  9. Sacchi  CT, Lemos  APS, Brandt  ME, Whitney  AM, Melles  CAE, Solari  CA, Proposed standardization of Neisseria meningitidis PorA variable-region typing nomenclature. Clin Diagn Lab Immunol. 1998;5:84555.PubMedGoogle Scholar
  10. Kwara  A, Adegbola  RA, Corrah  PT, Weber  M, Achtman  M, Morelli  G, Meningitis caused by a serogroup W135 clone of the ET-37 complex of Neisseria meningitidis in West Africa. Trop Med Int Health. 1998;3:7426.PubMedGoogle Scholar
  11. Maiden  MCJ, Bygraves  JA, Feil  E, Morelli  G, Russell  JE, Urwin  R, Multilocus sequence typing: a portable approach to the identification of clones within populations of pathogenic microorganisms. Proc Natl Acad Sci U S A. 1998;95:31405. DOIPubMedGoogle Scholar


Cite This Article

DOI: 10.3201/eid0604.000423

Related Links


Table of Contents – Volume 6, Number 4—August 2000

Page created: December 16, 2010
Page updated: December 16, 2010
Page reviewed: December 16, 2010
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.